Luzon, Ryan Brylle B.

HRN: 27-85-19  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/26/2025
COTRIMOXAZOLE 960MG (TAB)
09/26/2025
10/10/2025
PO
2 Tabs
TID
Immunocompromised State
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines